| Serial Number | 97594882 |
| Word Mark | IMMUNITYBIO |
| Filing Date | Friday, September 16, 2022 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Monday, August 5, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations and substances for the prevention, diagnosis, and treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; biological preparations for medical purposes, namely, vaccines for human use and animal use; low-dose chemotherapies, low dose radiation therapies, and personalized neoepitope-targeted therapies, all of the foregoing in the nature of pharmaceutical preparations for medical use for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases, and cancer; anti-cancer preparations; vaccines; biologics, namely, cell-derived preparations, cell therapies, monoclonal antibodies, cytokines, immune modulators, low-dose chemotherapy, low-dose radiation therapy, antibodies, fusion proteins, peptide and cytokine biologics, vaccines, personalized neoepitope-based therapies, cell therapies, and natural killer cell derived preparations, all of the foregoing in the nature of pharmaceutical preparations for clinical, medicinal, therapeutic, and veterinary purposes; kits for clinical, medicinal, therapeutic, and veterinary purposes comprised of clinical medical reagents, cell cultures media for laboratory use, and related printer user instructions sheets |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 3, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, January 18, 2022 |
| First Use In Commerce Date | Tuesday, July 19, 2022 |
| Party Name | NANTCELL, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Culver City, CA 92032 |
| Event Date | Event Description |
| Monday, October 3, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 20, 2022 | NEW APPLICATION ENTERED |
| Tuesday, June 27, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, June 27, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 27, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, June 27, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 27, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, September 27, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, December 20, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, December 20, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 21, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, February 5, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, February 5, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, February 5, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, May 6, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Monday, May 6, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Monday, August 5, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, August 5, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |